Drug Trial Radar · NCT07272330
A Phase I Trial on the Relative Bioavailability and Food Effect of HRS-1893 Tablets in Healthy Subjects
Last checked: Nov 20, 2026Latest source record: Apr 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
38
Actual
Start
Dec 11, 2025
Primary completion
Mar 21, 2026
Study completion Mar 21, 2026
Sponsor
- Lead sponsor
- Shandong Suncadia Medicine Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Dec 9, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Crossover
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 55 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This Phase I clinical trial will investigate the relative bioavailability between two formulations of HRS-1893 tablets and the influence of food on the drug's pharmacokinetics in healthy adult participants. The safety and tolerability of HRS-1893 will also be monitored.
Conditions
- Cardiomyopathy
Interventions
HRS-1893 tablet ADrug
Specified dose on specified days.
HRS-1893 tablet BDrug
Specified dose on specified days.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Peak concentration (Cmax)Time frame: From Day 1 to Day 25 in part 1, from Day 1 to Day 17 in part 2.
- Area under the plasma concentration-time curve from time zero to the last quantifiable time point (AUC0-t)Time frame: From Day 1 to Day 25 in part 1, from Day 1 to Day 17 in part 2.
- Area under the plasma concentration-time curve from time zero extrapolated to infinity (AUC0-∞)Time frame: From Day 1 to Day 25 in part 1, from Day 1 to Day 17 in part 2.
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Beijing Anzhen Hospital, Capital Medical University
Beijing, Beijing Municipality, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.